Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
5 drugs for “Epilepsy”
Phase 3 3
- RAP-219Rapport Therapeutics, Inc.Epilepsy; Focal Epilepsy
- VormatroginePraxis Precision Medicines, Inc.Epilepsy, Tonic-Clonic
- XEN1101Xenon Pharmaceuticals Inc.Focal Epilepsy
Phase 2/3 2
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.